According to Toujing Life's announcement, the holding subsidiaries Jiangxi Toujing and Maxbiotech have recently obtained medical device registration certificates issued by the Jiangxi Drug Administration and the Shanghai Drug Administration respectively, involving fully automated flow fluorescence fluorescence immunoassay analyzers and four anti-seizure drug concentration measurement kits. The registration certificates are valid until September 3, 2031 and September 16, 2031, respectively.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.